Number Of NuvaRing Lawsuits Filed Against Merck Increases, And New Evidence That NuvaRing Causes Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Blood Clots

(Posted by Tom Lamb at DrugInjuryWatch.com)

______________________________________________________________________________

UPDATE: "Merck to pay $100 million in NuvaRing contraceptive settlement" (2/7/14, Reuters)

(2/10/14)

______________________________________________________________________________

During the past year we have reported periodically on the NuvaRing drug injury lawsuits – both the federal court NuvaRing MDL pending before Judge Rodney Sippel and the New Jersey state court consolidated NuvaRing litigation being handled by Judge Brian Martinotti — as well as medical studies that link Merck's NuvaRing vaginal ring to an increased risk of blood clots that can cause deep vein thrombosis (DVT) and/or pulmonary embolism (PE), some of which resulted in the death of a woman or a girl.

We present this round-up of those Drug Injury Watch articles, now, in order to put in front of you the various reports of significant developments.

Articles About NuvaRing Lawsuits 2012 – 2013:

NuvaRing Update 2013: More NuvaRing Lawsuits Filed According To Merck Report; First NuvaRing Trial Dates Moved Back (Again)

NuvaRing: Plaintiffs' Expert Reports Made Available By New Jersey Judge Based On Public's Right Of Access To Judicial Proceedings

Disturbing Information About NuvaRing Safety Found In Motions On Experts Recently Unsealed By Federal Court MDL Judge

 _____________________________________________________________________

Free NuvaRing Case Evaluation 
Strictly Confidential, No Obligation.

______________________________________________________________________________

Articles About NuvaRing Blood Clot-Related Side Effects Such As PEs, DVTs, Strokes, Heart Attacks:

Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

New 2012 Medical Study Shows NuvaRing Doubles The Risk Of Stroke And Heart Attack, And The Degree Of Risk Increases With Age

Merck's NuvaRing Increases The Relative Risk For Blood-Clot Side Effects Says Medical Expert After Weighing Competing Studies

Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk

Of course, we will continue to monitor both the legal and medical aspects of the NuvaRing lawsuits being filed on behalf of women and girls who have suffered a pulmonary embolism (PE), deep vein thrombosis (DVT), or some other blood clot-related condition. e.g., stroke or heart attack, resulting in serious injury or death.

______________________________________________________________________________

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation – Free & Confidential  (Review done by attorney Tom Lamb)